bromocriptine has been researched along with Disease Models, Animal in 82 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (15.85) | 18.7374 |
| 1990's | 22 (26.83) | 18.2507 |
| 2000's | 21 (25.61) | 29.6817 |
| 2010's | 19 (23.17) | 24.3611 |
| 2020's | 7 (8.54) | 2.80 |
| Authors | Studies |
|---|---|
| Bagli, J; Bogri, T; Voith, K | 1 |
| Braisted, J; Dranchak, P; Earnest, TW; Gu, X; Hoon, MA; Inglese, J; Oliphant, E; Solinski, HJ | 1 |
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Chen, Y; Wang, A; Wang, S; Wang, X; Wu, J; Zhang, Y; Zhu, K | 1 |
| Akopian, AN; Dussor, GO; Kallianpur, R; Mason, BN; Price, TJ | 1 |
| Alam, MS; Ansari, MA; Ashraf, GM; Barkat, MA; Barreto, GE; Javed, MN; Nigar, S; Pottoo, FH; Sharma, S; Tabassum, N | 1 |
| Balbo, SL; Bertasso, IM; Bonfleur, ML; da Silva, BS; de Moura, EG; Lisboa, PC; Manhães, AC; Miranda, RA; Oliveira, E; Pietrobon, CB | 1 |
| Huang, X; Mailman, RB; Yang, Y | 1 |
| Barra, C; Conde, SV; Costa, A; Gasparini, P; Marques, D; Matafome, P; Melo, BF; Rodrigues, T; Rosendo-Silva, D; Sacramento, JF; Seiça, R; Tavares, G | 1 |
| Aluko, OM; Annafi, OS; Eduviere, AT; Omorogbe, O; Umukoro, S | 1 |
| Alam, MS; Ansari, MA; Ashraf, GM; Barkat, MA; Barreto, GE; Javed, MN; Khan, A; Maqbool, A; Nigar, S; Pottoo, FH; Rasheed, R; Tabassum, N | 1 |
| Choi, EH; Gardella, A; Kefalov, VJ; Leinonen, H; Palczewski, K | 1 |
| Lajud, N; Olvera-Cortés, E; Quintanar-Stéphano, A; Tinajero, E; Torner, L | 1 |
| Goto, K; Kaneko, Y; Narita, I; Otsuka, T; Saito, A; Tsuchida, Y; Yamamoto, K; Yamamoto, T | 1 |
| Ali, J; Baboota, S; Fazil, M; Haque, S; Kumar, M; Md, S; Sahni, JK | 1 |
| Ghumatkar, PJ; Jain, PD; Patil, SP; Sancheti, JS; Sathaye, S; Tambe, R | 1 |
| Aydogan, U; Cengiz, M; Ercan, CM; Ergun, A; Ide, T; Kayaalp, O; Keskin, U; Yumusak, N | 1 |
| Hou, L; Qin, F; Wang, C; Wang, L; Wang, X; Wei, Y; Yu, Z; Zhou, W | 1 |
| Ali, F; Fatima, A; Jyoti, S; Khan, W; Khanam, S; Naqvi, AH; Naz, F; Siddique, YH; Singh, BR | 1 |
| Chen, W; Chen, X; Qian, X; Wu, R; Xie, H; Yang, X; Zhang, Y | 1 |
| Espinoza, LR; Jara, LJ; Medina, G; Navarro, C; Saavedra, MA; Torres-Aguilar, H; Vazquez Del Mercado, M; Vera-Lastra, O | 1 |
| Cenci, MA; Lindgren, HS; Ohlin, KE | 1 |
| Chacun, H; Farinotti, R; Fernandez, C; Lacomblez, L; Milane, A; Vautier, S | 1 |
| Bultmann, I; Hilfiker-Kleiner, D; Sliwa, K; Yamac, H | 1 |
| Hadano, S; Ikeda, JE; Kanno, T; Tanaka, K; Yanagisawa, Y; Yasutake, K; Yoshii, F | 1 |
| Arany, Z; Bauersachs, J; Burke, SD; del Monte, F; Farrell, C; Hacker, MR; Hess, P; Hilfiker-Kleiner, D; Jang, C; Karumanchi, SA; Khankin, EV; Koulisis, N; Liu, L; Mahmood, F; Mitchell, J; Patten, IS; Rana, S; Rhee, JS; Rowe, GC; Shahul, S; Tudorache, I | 1 |
| Feng, YB; McAlonan, GM; Sze, SC; Wang, D; Wang, XM; Wong, HK; Zhang, L; Zhang, ZJ | 1 |
| Ahtiainen, P; Calandra, RS; Di Giorgio, NP; Gonzalez, B; Huhtaniemi, IT; Poutanen, M; Ratner, LD; Rulli, SB | 1 |
| Ali, J; Baboota, S; Chuttani, K; Khan, RA; Md, S; Mustafa, G; Sahni, JK | 1 |
| Bar-Gad, I; Bergman, H; Goldberg, JA; Heimer, G | 1 |
| Kondo, T | 1 |
| Ellersieck, MR; Ganjam, VK; Johnson, PJ; Loch, WE; Messer, NT; Refsal, KR; Thompson, DL | 1 |
| Atsumi, M; Iga, T; Kawakami, J; Kotaki, H; Sato, H; Sawada, Y; Sugiyama, E; Yamada, Y | 1 |
| Dixon, CE; Kline, AE; Ma, X; Massucci, JL; Zafonte, RD | 1 |
| Aley-Medina, P; Avila-Costa, MR; Colín-Barenque, L; Fortoul, TI; Librado, JL; Martínez, EF; Martínez, VA; Montiel-Flores, E; Mussali-Galante, P; Valdez, AL | 1 |
| Cheskin, LJ; Contoreggi, C; Davis, LM; McCullough, K; Moran, TH; Pei, Z; Trush, MA; Watkins, PA | 1 |
| Leinwand, LA | 1 |
| Ansari, A; Balligand, JL; Bonda, T; Desjardins, F; Doerries, C; Drexler, H; Forster, O; Heusch, G; Hilfiker, A; Hilfiker-Kleiner, D; Kaminski, K; Klein, G; Landmesser, U; Luchtefeld, M; Nguyen, NQ; Podewski, E; Poli, V; Quint, A; Schaefer, A; Schneider, MD; Schulz, R; Sliwa, K; Struman, I; Zschemisch, NH | 1 |
| Humphreys, MH; Ni, XP | 1 |
| Bertaina-Anglade, V; Drieu la Rochelle, C; Jaffard, R; Marighetto, A; Morain, P; Philippin, JN; Valerio, S | 1 |
| Krieger, DT | 1 |
| Deupree, JD; Murrin, LC; Pfeiffer, RF; Schneider, MB | 1 |
| Klapproth, A; Oepen, H; Schneider, G | 1 |
| Dizerega, GS; Ross, GT | 1 |
| Cincotta, AH; Meier, AH | 1 |
| Aono, T; Irahara, M; Saito, S; Uemura, H; Yoneda, N | 1 |
| Afek, A; Blank, M; Buskila, D; Goldberg, I; Kopolovic, J; Krause, I; Shoenfeld, Y; Teitelbaum, D | 1 |
| Cvak, L; Golda, V | 1 |
| Allen, SH; Hoffman, RW; McMurray, RW; Walker, SE | 1 |
| George, SR; Ng, GY | 1 |
| Bankiewicz, KS; Belluzzi, JD; Domino, EF; May, JM; McAfee, DA | 1 |
| Shoenfeld, Y | 1 |
| Hannsson, I; Holmdahl, R; Mattsson, R | 1 |
| Krupina, NA; Kryzhanovskiĭ, GN; Orlova, IN | 1 |
| Akiyama, K; Ishihara, T; Kashihara, K; Shiro, Y; Shohmori, T | 1 |
| Aguilar, R; Gaytán, F; Ruiz, A; Sánchez-Criado, JE; Tébar, AM | 1 |
| Brotchie, JM; Crossman, AR; Henry, B | 1 |
| Cincotta, AH; Jetton, TL; Liang, Y; Lubkin, M; Meier, AH | 1 |
| Inada, Y; Kojima, M; Komatsu, H; Miyata, H; Moro, M; Torii, R | 1 |
| Anic, T; Aralica, G; Bilic, I; Buljat, G; Ivankovic, D; Mikus, D; Mise, S; Perovic, D; Petek, M; Prkacin, I; Rotkvic, I; Rucman, R; Seiwerth, S; Separovic, J; Sikiric, P; Stancic-Rokotov, D; Zoricic, I | 1 |
| Kurasawa, M; Nakamura, K | 1 |
| Inada, Y; Kojima, M; Komatsu, H; Miyata, H; Moro, M; Tsujii, H | 1 |
| Kajimura, T; Satoh, H; Taya, K; Watanabe, G | 1 |
| Anić, B; Banić, M; Grabarević, Z; Herak-Perković, V; Novosel, V; Pogacnik, M | 1 |
| Andersson, M; Cenci, MA; Lundblad, M; Westin, JE | 1 |
| Walker, SE | 1 |
| Hillman, R; Parvez, F; Pendleton, RG; Sayed, M | 1 |
| Halbhübner, K; Herken, H; Loos, D | 1 |
| Albizzati, MG; Frattola, L; Scarlato, G; Trabucchi, M | 1 |
| Calne, DB | 1 |
| Muscat, R; Papp, M; Willner, P | 1 |
| Koob, GF; Markou, A | 1 |
| Chen, YJ; Chiou, GC | 1 |
| Décio, RC; Frussa-Filho, R; Monteiro, Mdo C; Soares, CG | 1 |
| Keck, PE; McElroy, SL; Pope, HG; Seeler, DC | 1 |
| Chevallier, P; Claustrat, B; Girod, C; Joly-Pharaboz, MO; Trouillas, J | 1 |
| Aguilar, E; Pinilla, L; Rodríguez-Padilla, ML | 1 |
| Nussenblatt, RB | 1 |
| Carvey, P; Goetz, CG; Klawans, HL; Paulseth, JE | 1 |
| Golda, V; Petr, R | 1 |
| Golda, V; Petr, R; Rozsíval, V; Suba, P | 1 |
| Collu, R; Eljarmak, D; Lis, M; Marchisio, AM | 1 |
6 review(s) available for bromocriptine and Disease Models, Animal
| Article | Year |
|---|---|
Prolactin: a new therapeutic target in peripartum cardiomyopathy.
Topics: Animals; Bromocriptine; Cardiomyopathies; Disease Models, Animal; Female; Hormone Antagonists; Humans; Mice; Oxidative Stress; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Puerperal Disorders | 2010 |
Initial therapy for Parkinson's disease: levodopa vs. dopamine receptor agonists.
Topics: Animals; Antiparkinson Agents; Bromocriptine; Contraindications; Disease Models, Animal; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine | 2002 |
Physiopathology of Cushing's disease.
Topics: Adenoma; Biomechanical Phenomena; Bromocriptine; Circadian Rhythm; Cushing Syndrome; Cyproheptadine; Disease Models, Animal; Forecasting; Glucocorticoids; Humans; In Vitro Techniques; Neurotransmitter Agents; Peptides; Pituitary Gland; Pituitary Hormones, Anterior; Pituitary Neoplasms; Pro-Opiomelanocortin; Protein Precursors | 1983 |
Luteal phase dysfunction.
Topics: Animals; Bromocriptine; Clomiphene; Corpus Luteum; Disease Models, Animal; Endometrium; Female; Follicle Stimulating Hormone; Haplorhini; Humans; Luteal Phase; Luteinizing Hormone; Male; Menstruation; Menstruation Disturbances; Ovary; Pregnancy; Pregnancy Maintenance; Progesterone; Prolactin | 1981 |
Prolactin: a stimulator of disease activity in systemic lupus erythematosus.
Topics: Animals; Autoimmune Diseases; Bromocriptine; Disease Models, Animal; Female; Humans; Hyperprolactinemia; Lupus Erythematosus, Systemic; Mice; Mice, Inbred Strains; Prolactin; Receptors, Prolactin | 1995 |
Immunosuppression of experimental systemic lupus erythematosus and antiphospholipid syndrome.
Topics: Adjuvants, Immunologic; Androgens; Animals; Antibodies, Anti-Idiotypic; Antiphospholipid Syndrome; Aspirin; Bone Marrow Transplantation; Bromocriptine; Cyclosporine; Disease Models, Animal; Estrogens; Ethylenes; Heparin; Hydroxyquinolines; Immunoglobulins, Intravenous; Immunosuppression Therapy; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lymphocyte Transfusion; Mice; T-Lymphocytes, Regulatory | 1994 |
1 trial(s) available for bromocriptine and Disease Models, Animal
| Article | Year |
|---|---|
A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy.
Topics: Animals; Bromocriptine; Cardiomyopathies; Cathepsin D; Disease Models, Animal; Female; Heart Transplantation; Humans; Hypertrophy, Left Ventricular; Lactation; Lipoproteins, LDL; Male; Mice; Mice, Knockout; Myocardium; Myocytes, Cardiac; Neovascularization, Pathologic; Oxidative Stress; Peptide Fragments; Postpartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Puerperal Disorders; STAT3 Transcription Factor | 2007 |
75 other study(ies) available for bromocriptine and Disease Models, Animal
| Article | Year |
|---|---|
Troponoids. 6. Troponylpiperazines: a new class of dopamine agonists.
Topics: Animals; Bromocriptine; Cycloheptanes; Disease Models, Animal; Hydroxydopamines; Male; Oxidopamine; Parkinson Disease; Piperazines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Structure-Activity Relationship; Tropolone | 1984 |
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, Spinal; Humans; Mice, Inbred C57BL; Mice, Knockout; Neurons; Pruritus; Receptors, Atrial Natriuretic Factor; Reproducibility of Results; Signal Transduction; Small Molecule Libraries | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
The role of MAPK11/12/13/14 (p38 MAPK) protein in dopamine agonist-resistant prolactinomas.
Topics: Animals; Apoptosis; Bromocriptine; Cell Line, Tumor; Disease Models, Animal; Dopamine Agonists; Drug Resistance; Estradiol; Female; Gene Expression Regulation; Mitogen-Activated Protein Kinase 11; Mitogen-Activated Protein Kinase 12; Mitogen-Activated Protein Kinase 13; Mitogen-Activated Protein Kinase 14; p38 Mitogen-Activated Protein Kinases; Pituitary Neoplasms; Prolactin; Prolactinoma; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Signal Transduction | 2021 |
Prolactin signaling modulates stress-induced behavioral responses in a preclinical mouse model of migraine.
Topics: Animals; Behavior, Animal; Bromocriptine; Disease Models, Animal; Facial Pain; Female; Hormone Antagonists; Hyperalgesia; Male; Mice; Mice, Knockout; Migraine Disorders; Ovariectomy; Prolactin; Receptors, Prolactin; Sex Characteristics; Signal Transduction; Stress, Psychological | 2022 |
Raloxifene potentiates the effect of fluoxetine against maximal electroshock induced seizures in mice.
Topics: Animals; Anticonvulsants; Bromocriptine; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Electroshock; Fluoxetine; Glutamic Acid; Hippocampus; Mice; Neuropeptide Y; Oxidative Stress; Raloxifene Hydrochloride; Receptors, Dopamine; Receptors, Serotonin; Seizures; Signal Transduction | 2020 |
Hepatic lipid metabolism in adult rats using early weaning models: sex-related differences.
Topics: Acetyltransferases; Animals; Bromocriptine; Disease Models, Animal; Female; Hormone Antagonists; Humans; Lactation; Lipogenesis; Lipoproteins, VLDL; Liver; Male; Non-alcoholic Fatty Liver Disease; Oxidation-Reduction; Prolactin; Rats; Rats, Wistar; Sex Factors; Stearoyl-CoA Desaturase; Time Factors; Triglycerides; Weaning | 2020 |
D
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Brain; Bromocriptine; Chlorocebus aethiops; Disease Models, Animal; Dopamine Agonists; Levodopa; Male; Motor Activity; Parkinsonian Disorders; Phenanthridines; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2021 |
Dopamine D2 receptor agonist, bromocriptine, remodels adipose tissue dopaminergic signalling and upregulates catabolic pathways, improving metabolic profile in type 2 diabetes.
Topics: Adult; Aged; Animals; Bariatric Surgery; Bromocriptine; Cohort Studies; Diabetes Mellitus, Type 2; Disease Models, Animal; Dopamine; Dopamine Agonists; Female; Humans; Insulin Resistance; Intra-Abdominal Fat; Lipid Metabolism; Male; Metabolic Networks and Pathways; Metabolome; Metabolomics; Middle Aged; Obesity; Rats; Receptors, Dopamine D2 | 2021 |
Probable mechanisms involved in the antipsychotic-like activity of methyl jasmonate in mice.
Topics: Acetates; Animals; Antioxidants; Antipsychotic Agents; Brain; Bromocriptine; Cyclopentanes; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Ketamine; Locomotion; Male; Maze Learning; Memory; Memory Disorders; Mice; Oxidative Stress; Oxylipins; Psychotic Disorders; Stereotyped Behavior; Time Factors | 2017 |
The Synergistic Effect of Raloxifene, Fluoxetine, and Bromocriptine Protects Against Pilocarpine-Induced Status Epilepticus and Temporal Lobe Epilepsy.
Topics: Animals; Anticonvulsants; Bromocriptine; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Epilepsy, Temporal Lobe; Female; Fluoxetine; Hippocampus; Male; Mice; Neurons; Oxidative Stress; Pilocarpine; Raloxifene Hydrochloride; Status Epilepticus | 2019 |
A Mixture of U.S. Food and Drug Administration-Approved Monoaminergic Drugs Protects the Retina From Light Damage in Diverse Models of Night Blindness.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-1 Receptor Antagonists; Animals; Arrestins; Bromocriptine; Disease Models, Animal; G-Protein-Coupled Receptor Kinase 1; Light; Metoprolol; Mice; Night Blindness; Tamsulosin; Transducin; United States; United States Food and Drug Administration | 2019 |
Hyperprolactinemia impairs object recognition without altering spatial learning in male rats.
Topics: Analysis of Variance; Animals; Bromocriptine; Discrimination, Psychological; Disease Models, Animal; Dopamine Agonists; Enzyme-Linked Immunosorbent Assay; Hyperprolactinemia; Male; Maze Learning; Memory Disorders; Prolactin; Rats; Rats, Sprague-Dawley; Recognition, Psychology; Space Perception | 2013 |
Upregulation of prolactin receptor in proximal tubular cells was induced in cardiac dysfunction model mice.
Topics: Acute Kidney Injury; Animals; Bromocriptine; Cardiomegaly; Disease Models, Animal; Homeostasis; Hormone Antagonists; Kidney Tubules, Proximal; Male; Mice, Inbred C57BL; Natriuresis; Potassium; Prolactin; Receptors, Prolactin; Reperfusion Injury; Sodium; Sodium Chloride, Dietary; Up-Regulation | 2014 |
Optimised nanoformulation of bromocriptine for direct nose-to-brain delivery: biodistribution, pharmacokinetic and dopamine estimation by ultra-HPLC/mass spectrometry method.
Topics: Administration, Intranasal; Animals; Antiparkinson Agents; Biological Availability; Biological Transport; Blood-Brain Barrier; Brain; Bromocriptine; Chitosan; Chromatography, High Pressure Liquid; Disease Models, Animal; Dopamine; Drug Delivery Systems; Female; Male; Mass Spectrometry; Mice; Nanoparticles; Nasal Mucosa; Parkinson Disease; Radiopharmaceuticals; Sodium Pertechnetate Tc 99m; Tissue Distribution | 2014 |
RETRACTED: Neuroprotective and neurotrophic effects of Apigenin and Luteolin in MPTP induced parkinsonism in mice.
Topics: Animals; Apigenin; Brain-Derived Neurotrophic Factor; Bromocriptine; Disease Models, Animal; Dose-Response Relationship, Drug; Glial Fibrillary Acidic Protein; Luteolin; Male; Mice; Motor Activity; MPTP Poisoning; Neuroprotective Agents; Oxidative Stress; Pars Compacta; Random Allocation; Tumor Necrosis Factor-alpha; Tyrosine 3-Monooxygenase | 2014 |
Comparison of efficacy of bromocriptine and cabergoline to GnRH agonist in a rat endometriosis model.
Topics: Adult; Animals; Antineoplastic Agents; Bromocriptine; Cabergoline; Disease Models, Animal; Dopamine Agonists; Endometriosis; Endometrium; Ergolines; Female; Gonadotropin-Releasing Hormone; Humans; Laparotomy; Leuprolide; Prospective Studies; Random Allocation; Rats; Rats, Wistar; Triptorelin Pamoate | 2015 |
Efficacy and Mechanism of Action of Yiru Tiaojing Granule Against Hyperprolactinemia In Vitro and In Vivo.
Topics: Animals; Brain; Bromocriptine; Cell Line; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Female; Haloperidol; Hyperprolactinemia; Medicine, Chinese Traditional; Progesterone; Prolactin; Rats, Sprague-Dawley; Receptors, Dopamine D2 | 2015 |
Effect of bromocriptine alginate nanocomposite (BANC) on a transgenic Drosophila model of Parkinson's disease.
Topics: Alginates; Animals; Animals, Genetically Modified; Brain; Bromocriptine; Crosses, Genetic; Disease Models, Animal; Dose-Response Relationship, Drug; Drosophila melanogaster; Female; Glutathione; Glutathione Transferase; Lipid Peroxidation; Male; Nanocomposites; Parkinson Disease; Permeability; Solubility; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared | 2016 |
Therapeutic effects of Wharton jelly-derived mesenchymal stem cells on rat abortion models.
Topics: Abortion, Spontaneous; Animals; Bromocriptine; Disease Models, Animal; Female; Humans; Interferon-gamma; Interleukin-10; Interleukin-17; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Placenta; Pregnancy; Rats; Rats, Sprague-Dawley; RNA, Messenger; Wharton Jelly | 2016 |
Prolactin has a pathogenic role in systemic lupus erythematosus.
Topics: Adaptive Immunity; Animals; Antibodies, Antinuclear; Bromocriptine; Disease Models, Animal; Dopamine Agonists; Female; Humans; Hyperprolactinemia; Immunity, Innate; Immunocompetence; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Pregnancy; Pregnancy Complications; Prolactin; Receptors, Prolactin | 2017 |
Differential involvement of D1 and D2 dopamine receptors in L-DOPA-induced angiogenic activity in a rat model of Parkinson's disease.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aminoacetonitrile; Animals; Antiparkinson Agents; Basal Ganglia; Benzazepines; Bromocriptine; Disease Models, Animal; Dopamine Agents; Dopamine D2 Receptor Antagonists; Extracellular Signal-Regulated MAP Kinases; Female; Levodopa; Neovascularization, Pathologic; Oxidopamine; Parkinsonian Disorders; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides | 2009 |
Role of two efflux proteins, ABCB1 and ABCG2 in blood-brain barrier transport of bromocriptine in a murine model of MPTP-induced dopaminergic degeneration.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Blood-Brain Barrier; Blotting, Western; Brain; Bromocriptine; Disease Models, Animal; Gene Expression Regulation; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Parkinson Disease; Tissue Distribution | 2009 |
Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Anterior Horn Cells; Bromocriptine; Disease Models, Animal; Disease Progression; Dopamine Agonists; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Neuroglia; Neuronal Apoptosis-Inhibitory Protein; Receptors, Dopamine D2; Spinal Cord; Superoxide Dismutase; Superoxide Dismutase-1; Treatment Outcome; Up-Regulation | 2011 |
Cardiac angiogenic imbalance leads to peripartum cardiomyopathy.
Topics: Animals; Bromocriptine; Cardiomyopathies; Disease Models, Animal; Female; Heart; Humans; Kaplan-Meier Estimate; Male; Mice; Mice, Knockout; Myocytes, Cardiac; Neovascularization, Pathologic; Neovascularization, Physiologic; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Trans-Activators; Transcription Factors; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1 | 2012 |
Not only dopamine D2 receptors involved in Peony-Glycyrrhiza Decoction, an herbal preparation against antipsychotic-associated hyperprolactinemia.
Topics: Animals; Bromocriptine; Cell Line; Disease Models, Animal; Dopamine; Dopamine D2 Receptor Antagonists; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Estradiol; Female; Glycyrrhiza; Haloperidol; Herb-Drug Interactions; Hyperprolactinemia; Metoclopramide; Paeonia; PC12 Cells; Phytotherapy; Plant Extracts; Progesterone; Prolactin; Rabbits; Rats, Sprague-Dawley; Receptors, Dopamine D2 | 2012 |
Short-term pharmacological suppression of the hyperprolactinemia of infertile hCG-overproducing female mice persistently restores their fertility.
Topics: Animals; Bromocriptine; Cabergoline; Chorionic Gonadotropin; Disease Models, Animal; Ergolines; Female; Fertility; Gene Expression Regulation; Humans; Hyperprolactinemia; Infertility; Mice; Mice, Transgenic; Ovulation; Phenotype; Time Factors | 2012 |
Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model.
Topics: Administration, Intranasal; Animals; Antiparkinson Agents; Behavior, Animal; Blood-Brain Barrier; Brain; Bromocriptine; Catalepsy; Chitosan; Disease Models, Animal; Drug Compounding; Drug Delivery Systems; Hypokinesia; Injections, Intravenous; Male; Mice; Nanoparticles; Neurons; Parkinson Disease; Radionuclide Imaging; Random Allocation; Sodium Pertechnetate Tc 99m; Tissue Distribution | 2013 |
Dopamine replacement therapy reverses abnormal synchronization of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Action Potentials; Animals; Antiparkinson Agents; Bromocriptine; Carbidopa; Chlorocebus aethiops; Disease Models, Animal; Dopamine; Dopamine Agonists; Drug Therapy, Combination; Electrodes, Implanted; Female; Globus Pallidus; Levodopa; Neurons; Organic Chemicals; Parkinsonian Disorders | 2002 |
Effects of propylthiouracil and bromocryptine on serum concentrations of thyrotrophin and thyroid hormones in normal female horses.
Topics: Animals; Antithyroid Agents; Bromocriptine; Disease Models, Animal; Female; Hormone Antagonists; Horse Diseases; Horses; Hypothyroidism; Propylthiouracil; Thyroid Hormones; Thyrotropin; Thyroxine; Triiodothyronine | 2003 |
Pharmacokinetic and pharmacodynamic analyses, based on dopamine D2-receptor occupancy of bromocriptine, of bromocriptine-induced contralateral rotations in unilaterally 6-OHDA-lesioned rats.
Topics: Animals; Bromocriptine; Denervation; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Male; Neostriatum; Neural Pathways; Neurons; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Dopamine D2; Rotation; Substantia Nigra | 2003 |
Bromocriptine reduces lipid peroxidation and enhances spatial learning and hippocampal neuron survival in a rodent model of focal brain trauma.
Topics: Animals; Brain Injuries; Bromocriptine; Disease Models, Animal; Dopamine Agonists; Hippocampus; Lipid Peroxidation; Male; Maze Learning; Oxidative Stress; Rats; Rats, Sprague-Dawley; Thiobarbituric Acid Reactive Substances | 2004 |
Bromocriptine treatment in a murine Parkinson's model: ultrastructural evaluation after dopaminergic deafferentation.
Topics: Animals; Antiparkinson Agents; Bromocriptine; Caudate Nucleus; Disease Models, Animal; Dopamine; Male; Motor Endplate; Oxidative Stress; Parkinson Disease; Rats; Rats, Wistar | 2005 |
Bromocriptine reduces steatosis in obese rodent models.
Topics: Animals; Blood Glucose; Body Composition; Bromocriptine; Disease Models, Animal; Dopamine Agonists; Eating; Fatty Liver; Liver; Locomotion; Male; Obesity; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Zucker; Superoxide Dismutase; Triglycerides | 2006 |
Molecular events underlying pregnancy-induced cardiomyopathy.
Topics: Animals; Bromocriptine; Cardiomyopathies; Cathepsin D; Disease Models, Animal; Female; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Puerperal Disorders; STAT3 Transcription Factor | 2007 |
Prevention of salt-induced hypertension by an analog of gamma-melanocyte-stimulating hormone in the rat.
Topics: Animals; Blood Pressure; Blood Pressure Determination; Bromocriptine; Disease Models, Animal; Dopamine Agonists; Follow-Up Studies; gamma-MSH; Hormones; Hypertension; Infusion Pumps, Implantable; Male; Rats; Rats, Sprague-Dawley; Sodium Chloride, Dietary; Telemetry; Treatment Outcome | 2007 |
Comparative effects of the dopaminergic agonists piribedil and bromocriptine in three different memory paradigms in rodents.
Topics: Aging; Animals; Antiparkinson Agents; Bromocriptine; Discrimination Learning; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Injections, Subcutaneous; Male; Maze Learning; Memory; Memory Disorders; Mice; Mice, Inbred C57BL; Piribedil; Rats; Rats, Sprague-Dawley | 2008 |
Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Bromocriptine; Corpus Striatum; Disease Models, Animal; Dopamine; Humans; Hydroxydopamines; Kinetics; Levodopa; Male; Membranes; Oxidopamine; Parkinson Disease; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Stereotyped Behavior; Substantia Nigra | 1984 |
[Symptomatic therapy in a possible animal model for Huntington's chorea].
Topics: Animals; Bromocriptine; Disease Models, Animal; Glucosamine; Huntington Disease; Isoniazid; Male; Nitriles; Rats | 1981 |
Bromocriptine inhibits in vivo free fatty acid oxidation and hepatic glucose output in seasonally obese hamsters (Mesocricetus auratus).
Topics: Animals; Blood Glucose; Bromocriptine; Circadian Rhythm; Cricetinae; Disease Models, Animal; Energy Metabolism; Fatty Acids, Nonesterified; Female; Glucose; Hormone Antagonists; Hyperinsulinism; Insulin; Insulin Resistance; Lipolysis; Liver; Mesocricetus; Obesity; Oxidation-Reduction; Seasons | 1995 |
Usefulness of recombinant human prolactin for treatment of poor puerperal lactation in a rat model.
Topics: Analysis of Variance; Animals; Birth Weight; Bromocriptine; Disease Models, Animal; Female; Hormone Antagonists; Humans; Lactation; Lactation Disorders; Mammary Glands, Animal; Postpartum Period; Prolactin; Radioimmunoassay; Random Allocation; Rats; Rats, Wistar; Recombinant Proteins; Transfection | 1995 |
Bromocriptine immunomodulation of experimental SLE and primary antiphospholipid syndrome via induction of nonspecific T suppressor cells.
Topics: Animals; Antibodies, Monoclonal; Antiphospholipid Syndrome; Autoantibodies; Bromocriptine; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Lupus Erythematosus, Systemic; Lymph Nodes; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Suppressor Factors, Immunologic; T-Lymphocytes, Regulatory | 1995 |
Terguride but not bromocriptine alleviated glucose tolerance abnormalities and hyperlipidaemia in obese and lean genetically hypertensive Koletsky rats.
Topics: Animals; Blood Pressure; Body Weight; Bromocriptine; Disease Models, Animal; Female; Glucose Intolerance; Hyperlipidemias; Hypertension; Insulin; Lipids; Lisuride; Male; Obesity; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Rats, Wistar; Sex Factors | 1994 |
Dopamine receptor agonist reduces ethanol self-administration in the ethanol-preferring C57BL/6J inbred mouse.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Alcoholism; Animals; Blotting, Northern; Brain; Bromocriptine; Computer Simulation; Disease Models, Animal; Down-Regulation; Ethanol; Male; Mice; Mice, Inbred C57BL; Radioligand Assay; Receptors, Dopamine D1; Receptors, Dopamine D2; Regression Analysis; RNA, Messenger; Self Administration | 1994 |
N-0923, a selective dopamine D2 receptor agonist, is efficacious in rat and monkey models of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Bromocriptine; Disease Models, Animal; Dominance, Cerebral; Dopamine Agents; Female; Injections, Intramuscular; Macaca nemestrina; Male; Oxazines; Oxidopamine; Parkinson Disease, Secondary; Prolactin; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Stereotyped Behavior; Substantia Nigra; Tetrahydronaphthalenes; Thiophenes | 1994 |
Pineal gland in autoimmunity: melatonin-dependent exaggeration of collagen-induced arthritis in mice.
Topics: Animals; Arthritis, Rheumatoid; Autoimmune Diseases; Autoimmunity; Bromocriptine; Collagen; Darkness; Disease Models, Animal; Drug Synergism; Endorphins; Female; Gonadal Steroid Hormones; Melatonin; Mice; Neuroimmunomodulation; Pineal Gland; Prolactin | 1994 |
[The effect of parlodel on development of depressive syndrome in rats, caused by administering 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Bromocriptine; Depressive Disorder; Disease Models, Animal; Dopamine Agonists; Drinking Behavior; Male; MPTP Poisoning; Rats; Rats, Wistar; Receptors, Dopamine D2 | 1995 |
Levodopoa but not bromocriptine induces AP-1 and creb DNA-binding activity in the dopamine-depleted striatum of the rat.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antiparkinson Agents; Base Sequence; Behavior, Animal; Bromocriptine; Corpus Striatum; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Dopamine; Dopamine Agonists; Levodopa; Male; Molecular Sequence Data; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Transcription Factor AP-1 | 1996 |
RU486-treated rats show endocrine and morphological responses to therapies analogous to responses of women with polycystic ovary syndrome treated with similar therapies.
Topics: Androgen Antagonists; Animals; Bromocriptine; Disease Models, Animal; Dopamine Agonists; Estrogen Antagonists; Female; Flutamide; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Mifepristone; Ovary; Ovulation; Polycystic Ovary Syndrome; Progesterone; Rats; Rats, Wistar; Tamoxifen | 1996 |
Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antiparkinson Agents; Behavior, Animal; Bromocriptine; Clonidine; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Dyskinesia, Drug-Induced; Levodopa; Lisuride; Locomotion; Male; Mazindol; Methoxydimethyltryptamines; Oxidopamine; Parkinson Disease, Secondary; Prosencephalon; Rats; Rats, Sprague-Dawley; Sympatholytics; Tritium; Yohimbine | 1998 |
Bromocriptine/SKF38393 ameliorates islet dysfunction in the diabetic (db/db) mouse.
Topics: Animals; Blood Glucose; Bromocriptine; Corticosterone; Diabetes Mellitus, Type 2; Disease Models, Animal; Dopamine Agonists; Fluorescent Antibody Technique; Immunohistochemistry; Insulin; Islets of Langerhans; Lipids; Mice; Mice, Obese; Pancreas | 1998 |
New hyperprolactinemia and anovulation model in common marmoset (Callithrix jacchus) and effect of cabergoline.
Topics: Animals; Anovulation; Bromocriptine; Cabergoline; Callithrix; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Ergolines; Estradiol; Female; Hyperprolactinemia; Menstrual Cycle; Progesterone; Prolactin; Sulpiride; Time Factors | 1999 |
Haloperidol-stomach lesions attenuation by pentadecapeptide BPC 157, omeprazole, bromocriptine, but not atropine, lansoprazole, pantoprazole, ranitidine, cimetidine and misoprostol in mice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Atropine; Benzimidazoles; Bromocriptine; Cimetidine; Disease Models, Animal; Domperidone; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Indomethacin; Lansoprazole; Male; Mice; Mice, Inbred Strains; Misoprostol; Omeprazole; Pantoprazole; Peptide Fragments; Proteins; Ranitidine; Stomach Diseases; Sulfoxides | 2001 |
Anxiolytic effects of aniracetam in three different mouse models of anxiety and the underlying mechanism.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Bromocriptine; Diazepam; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Fear; Fluvoxamine; Haloperidol; Indophenol; Male; Maze Learning; Mecamylamine; Mice; Mice, Inbred ICR; Moclobemide; Motor Activity; Nicotine; Nicotinic Antagonists; Nortriptyline; Physostigmine; Picolinic Acids; Pyrrolidinones; Serotonin Antagonists; Serotonin Receptor Agonists; Social Behavior; Stress, Psychological | 2001 |
Effects of dopamine d2 receptor agonists in a pituitary transplantation-induced hyperprolactinaemia/anovulation model in rats.
Topics: Animals; Anovulation; Bromocriptine; Disease Models, Animal; Dopamine Agonists; Estrus; Female; Gonadotropins; Hormones; Hyperprolactinemia; Organ Transplantation; Pituitary Gland; Prolactin; Rats; Rats, Wistar; Receptors, Dopamine D2 | 2001 |
Effect of hyperprolactinemia induced by pituitary grafts or castration on porphyrin content of the mouse Harderian gland.
Topics: Animals; Body Weight; Bromocriptine; Butyrophenones; Disease Models, Animal; Female; Harderian Gland; Hormone Antagonists; Hyperprolactinemia; Male; Mice; Mice, Inbred Strains; Orchiectomy; Organ Size; Organ Transplantation; Pituitary Gland, Anterior; Porphyrins; Prolactin; Testis; Testosterone | 2001 |
Effects of dopaminergic drugs on inflammatory bowel disease induced with 2,4-dinitrofluorbenzene in BALB/c mice.
Topics: Animals; Bromocriptine; Colon; Dinitrofluorobenzene; Disease Models, Animal; Domperidone; Dopamine Agonists; Dopamine Antagonists; Inflammatory Bowel Diseases; Injections, Intraperitoneal; Male; Mice; Mice, Inbred BALB C; Random Allocation | 2001 |
Persistent changes in striatal gene expression induced by long-term L-DOPA treatment in a rat model of Parkinson's disease.
Topics: Animals; Bromocriptine; Denervation; Disease Models, Animal; Dopamine Agents; Dopamine Agonists; Drug Administration Schedule; Enkephalins; Female; Gene Expression Regulation; Immunohistochemistry; Levodopa; Neostriatum; Oxidopamine; Parkinsonian Disorders; Protein Precursors; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sympatholytics | 2001 |
Bromocriptine treatment of systemic lupus erythematosus.
Topics: Animals; Autoimmunity; Bromocriptine; Disease Models, Animal; Humans; Lupus Erythematosus, Systemic; Prolactin | 2001 |
Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; alpha-Synuclein; Animals; Animals, Genetically Modified; Antiparkinson Agents; Bromocriptine; Disease Models, Animal; Drosophila melanogaster; Genotype; Levodopa; Motor Activity; Nerve Tissue Proteins; Neurons; Parkinson Disease; Pergolide; Postural Balance; Synapses; Synucleins | 2002 |
Experimental neuropathy with Parkinson-like muscular rigidity. A suitable model for testing dopaminergic agonists and neuroleptic drugs.
Topics: 6-Aminonicotinamide; Animals; Antipsychotic Agents; Baclofen; Brain; Brain Chemistry; Bromocriptine; Central Nervous System Diseases; Disease Models, Animal; Dopamine; Drug Evaluation, Preclinical; Electromyography; Gluconates; Levodopa; Lisuride; Male; Motor Neurons; Muscle Contraction; Niacinamide; Parkinson Disease, Secondary; Rats; Reserpine; RNA; Spinal Cord; Sugar Phosphates | 1978 |
Hemiparkinsonism. A human model for studying dopaminergic supersensitivity.
Topics: Animals; Antiparkinson Agents; Bromocriptine; Carbidopa; Dextroamphetamine; Disease Models, Animal; Humans; Levodopa; Male; Middle Aged; Movement; Parkinson Disease, Secondary; Receptors, Dopamine | 1979 |
Role of ergot derivatives in the treatment of parkinsonism.
Topics: Acetonitriles; Animals; Bromocriptine; Disease Models, Animal; Ergolines; Humans; Liver; Parkinson Disease; Pyridines; Structure-Activity Relationship | 1978 |
Antidepressant-like effects of dopamine agonists in an animal model of depression.
Topics: Animals; Arousal; Brain; Bromocriptine; Depressive Disorder; Disease Models, Animal; Dopamine Agents; Dose-Response Relationship, Drug; Drinking; Ergolines; Helplessness, Learned; Male; Motivation; Quinpirole; Rats; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Taste | 1992 |
Bromocriptine reverses the elevation in intracranial self-stimulation thresholds observed in a rat model of cocaine withdrawal.
Topics: Analysis of Variance; Animals; Bromocriptine; Cocaine; Disease Models, Animal; Male; Rats; Rats, Wistar; Regression Analysis; Self Stimulation; Substance Withdrawal Syndrome | 1992 |
Effects of dopamine agonist, bromocriptine, and some dopamine antagonists on ocular blood flow.
Topics: Animals; Blood Flow Velocity; Bromocriptine; Disease Models, Animal; Domperidone; Dopamine Antagonists; Eye; Haloperidol; Intraocular Pressure; Ocular Hypertension; Rabbits | 1992 |
Effects of haloperidol, bromocriptine and amphetamine on the development of Ehrlich ascites carcinoma in mice.
Topics: Amphetamine; Analysis of Variance; Animals; Bromocriptine; Carcinoma, Ehrlich Tumor; Disease Models, Animal; Haloperidol; Male; Mice; Neoplasm Transplantation; Random Allocation | 1992 |
Porcine stress syndrome: an animal model for the neuroleptic malignant syndrome?
Topics: Animals; Brain; Bromocriptine; Disease Models, Animal; Haloperidol; Halothane; Hyperthermia, Induced; Lithium; Lithium Carbonate; Neuroleptic Malignant Syndrome; Pilot Projects; Receptors, Dopamine; Swine; Swine Diseases | 1990 |
Spontaneous prolactin transplantable tumor in the Wistar/Furth rat (SMtTW): a new animal model of human prolactinoma.
Topics: Animals; Bromocriptine; Disease Models, Animal; Female; Microscopy, Electron; Neoplasm Transplantation; Pituitary Neoplasms; Prolactin; Prolactinoma; Rats | 1990 |
Normoprolactinaemia in spontaneously hypertensive rats: absence of a close relationship between plasma concentrations of prolactin and systolic blood pressure.
Topics: Animals; Bromocriptine; Disease Models, Animal; Female; Hyperprolactinemia; Hypertension; Immobilization; Male; Prolactin; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Serotonin; Testosterone | 1990 |
Basic and clinical immunology in uveitis.
Topics: Allergy and Immunology; Animals; Antibody Formation; Antigens; Arrestin; Biomechanical Phenomena; Bromocriptine; Cyclosporins; Disease Models, Animal; Eye Proteins; Humans; Immune System; Uveitis | 1987 |
L-5-HTP-induced myoclonic jumping behavior in guinea pigs: an update.
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Bromocriptine; Clonazepam; Disease Models, Animal; Guinea Pigs; Haloperidol; Lisuride; Morphine; Myoclonus; Naloxone; Scopolamine; Tremorine | 1986 |
Animal model of depression: retention of motor depression not predictable from the threshold of reaction to the inescapable shock.
Topics: Animals; Bromocriptine; Depression; Differential Threshold; Disease Models, Animal; Electroshock; Escape Reaction; Exploratory Behavior; Female; Forecasting; Imipramine; Male; Motor Activity; Rats; Rats, Inbred SHR; Rats, Inbred Strains | 1987 |
Animal model of depression: imipramine, bromocriptine and lisuride alleviate motor depression.
Topics: Adjustment Disorders; Animals; Bromocriptine; Disease Models, Animal; Ergolines; Female; Imipramine; Lisuride; Male; Motor Activity; Rats; Rats, Inbred Strains | 1986 |
Presence of high affinity dopamine receptors in estrone-induced, prolactin-secreting rat pituitary adenomas: a model for human prolactinomas.
Topics: Adenoma; Animals; Bromocriptine; Disease Models, Animal; Dopamine; Estrone; Female; Guanosine Triphosphate; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred F344; Receptors, Dopamine; Thyrotropin-Releasing Hormone | 1985 |